Table 1. Patient characteristics.
| Characteristics | No. of patients (%) | |
|---|---|---|
| Age (y) | ||
| Range, 17–70 | ||
| Median, 51 | ||
| Histopathologic diagnosis (adenocarcinoma) | ||
| Serous | 47/60 (78.3) | |
| Others (endometrioid, mucinous) | 13/60 (21.7) | |
| Normal (cancer-adjacent normal tissue) | 10 | |
| Grade | ||
| 1 | 13/60 (21.7) | |
| 2 | 26/60 (43.3) | |
| 3 | 21/60 (35.0) | |
| Disease stage | ||
| I | 38/60 (63.3) | |
| II | 18/60 (30.0) | |
| III | 3/60 (5.0) | |
| IV | 1/60 (1.7) | |
| p-PEA15-S104 expression | ||
| 1 (low) | 12/60 (20.0) | 10/10 (100) |
| 2 (moderate) | 22/60 (36.7) | 0 |
| 3 (high) | 26/60 (43.3) | 0 |
| p-PEA15-S116 expression | ||
| 1 (low) | 24/60 (40.0) | 1/10 (10) |
| 2 (moderate) | 20/60 (33.3) | 6/10 (60) |
| 3 (high) | 16/60 (26.7) | 3/10 (30) |
| β-Catenin expression | ||
| 0 (no expression) | 5/60 (8.3) | 0 |
| 1 (low) | 34/60 (56.7) | 5/10 (50) |
| 2 (moderate) | 14/60 (23.3) | 5/10 (50) |
| 3 (high) | 7/60 (11.7) | 0 |